STERIS Corp (NYSE:STE), a leading provider of sterilization and surgical equipment, has landed a $450 million contract modification from the U.S. Department of Defense (DoD). The extension builds on an existing five-year base contract, adding an additional five-year option period that will run through June 22, 2030.
Based in Mentor, Ohio, STERIS will continue supplying patient monitoring systems and capital medical equipment under the updated agreement. The contract is structured as a fixed-price, indefinite-delivery/indefinite-quantity (IDIQ) arrangement, with economic-price-adjustment provisions to account for market changes.
This extended contract supports various branches of the U.S. military—including the Army, Navy, Air Force, and Marine Corps—as well as other federal civilian agencies. Funding will be sourced from defense working capital funds allocated across fiscal years 2025 to 2030.
The agreement is managed by the Defense Logistics Agency Troop Support in Philadelphia, Pennsylvania, ensuring the continued delivery of essential healthcare equipment for U.S. armed forces and government entities.
STERIS's ongoing collaboration with the DoD reinforces its position as a trusted supplier in the healthcare and defense sectors. The deal not only enhances the company’s government portfolio but also underscores its commitment to supporting national medical readiness and infrastructure.
With growing demand for advanced medical technologies across defense and public health sectors, STERIS is poised to further expand its role in supplying life-saving equipment to mission-critical operations. The multibillion-dollar healthcare technology firm continues to build on its reputation for quality and reliability in both commercial and government markets.
This contract extension marks another milestone for STERIS in strengthening its long-term government partnerships while contributing to the advancement of military medical capabilities.


United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure 



